[go: up one dir, main page]

LU85796A1 - Derives antipsychotiques de la 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine - Google Patents

Derives antipsychotiques de la 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine Download PDF

Info

Publication number
LU85796A1
LU85796A1 LU85796A LU85796A LU85796A1 LU 85796 A1 LU85796 A1 LU 85796A1 LU 85796 A LU85796 A LU 85796A LU 85796 A LU85796 A LU 85796A LU 85796 A1 LU85796 A1 LU 85796A1
Authority
LU
Luxembourg
Prior art keywords
compound
formula
fluorophenyl
compound according
fluoro
Prior art date
Application number
LU85796A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU85796A1 publication Critical patent/LU85796A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Legs For Furniture In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU85796A 1984-03-06 1985-03-05 Derives antipsychotiques de la 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine LU85796A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58658084A 1984-03-06 1984-03-06
US58658084 1984-03-06
US06/683,309 US4605655A (en) 1984-03-06 1984-12-18 Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US68330984 1984-12-18

Publications (1)

Publication Number Publication Date
LU85796A1 true LU85796A1 (fr) 1985-12-12

Family

ID=27079753

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85796A LU85796A1 (fr) 1984-03-06 1985-03-05 Derives antipsychotiques de la 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine

Country Status (27)

Country Link
US (1) US4605655A (hu)
KR (3) KR920005113B1 (hu)
AT (1) AT390951B (hu)
AU (1) AU576555B2 (hu)
BE (1) BE901880A (hu)
CA (1) CA1256871A (hu)
CH (1) CH663022A5 (hu)
CY (1) CY1545A (hu)
DE (1) DE3507983A1 (hu)
DK (1) DK166149C (hu)
ES (1) ES8607254A1 (hu)
FI (1) FI84478C (hu)
FR (1) FR2560878B1 (hu)
GB (1) GB2155925B (hu)
GR (1) GR850561B (hu)
HK (1) HK82890A (hu)
HU (1) HU193949B (hu)
IE (1) IE58338B1 (hu)
IT (1) IT1183483B (hu)
LU (1) LU85796A1 (hu)
MX (1) MX9203177A (hu)
MY (1) MY102240A (hu)
NL (1) NL8500628A (hu)
PT (1) PT80058B (hu)
SE (1) SE462429B (hu)
SG (1) SG35590G (hu)
ZA (1) ZA851486B (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
MX173180B (es) * 1987-10-26 1994-02-07 Pfizer Procedimiento para preparar agentes ansioliticos
US4882432A (en) * 1989-01-09 1989-11-21 American Home Products Corporation Polycyclic-carbamic acid piperazinoalkyl esters and amides
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
IE64038B1 (en) * 1989-04-22 1995-06-28 Wyeth John & Brother Ltd Tertiary alkyl functionalized piperazine derivatives
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
US5646281A (en) * 1990-12-28 1997-07-08 Neurogen Corporation Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
EP0538693A3 (en) * 1991-10-23 1994-08-17 Squibb & Sons Inc Stereoselective preparation of halophenyl alcohols
TW217382B (hu) * 1991-10-24 1993-12-11 Bristol Myers Squibb Co
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
ES2074946B1 (es) * 1993-07-19 1996-06-16 Ferrer Int Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
EP0757040A4 (en) * 1994-04-18 1997-07-16 Asahi Chemical Ind ADAMANTANE DERIVATIVE, PROCESS FOR PRODUCTION AND USE OF SAID DERIVATIVE
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
ES2104509B1 (es) * 1995-06-13 1998-07-01 Ferrer Int Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
PT2155736E (pt) * 2007-05-14 2012-03-28 Sk Biopharmaceuticals Co Ltd Novo composto carbamoiloxiarilalcanoilarilpiperazina, composições farmacêuticas compreendendo este composto e método para tratamento da dor, ansiedade e depressão pela administração do composto
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
EP4153209A1 (en) 2020-05-20 2023-03-29 The Board of Trustees of the University of Illinois Method for treating lysosomal storage diseases with histatin peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2973360A (en) * 1959-10-12 1961-02-28 Paul A J Janssen Certain 1-(2-theonyl lower alkyl)-4-(heterocyclic substituted)-piperazines
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
NL127996C (hu) * 1963-11-19
GB1259685A (en) * 1969-04-03 1972-01-12 Soc D Etudes Prod Chimique Amino-pyrimidine derivatives
BE758380A (fr) * 1969-11-04 1971-04-16 Sumitomo Chemical Co Procede de preparation de derives d'aryl-cetones
GB1307256A (en) * 1970-09-15 1973-02-14 Science Union & Cie Piperazine derivatives and a process for their preparation
BE882836A (fr) * 1979-05-15 1980-08-18 Soc D Etudes Prod Chimique Nouveaux derives halogenes de l'isopropylamino pyrimidine, leur preparation et leur utilisaton therapeutique
US4316899A (en) * 1979-08-24 1982-02-23 Beecham Group Limited Chromanone derivatives, a process for their preparation and compositions containing them
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
US4605655A (en) 1986-08-12
DK166149C (da) 1993-08-09
FI850850L (fi) 1985-09-07
SE8501067L (sv) 1985-09-07
ATA64985A (de) 1990-01-15
FI850850A0 (fi) 1985-03-01
ES540901A0 (es) 1986-05-16
SG35590G (en) 1990-07-13
GB8505662D0 (en) 1985-04-03
NL8500628A (nl) 1985-10-01
MY102240A (en) 1992-05-15
KR850006402A (ko) 1985-10-05
HUT37781A (en) 1986-02-28
FR2560878A1 (fr) 1985-09-13
CY1545A (en) 1991-03-22
KR920005694B1 (ko) 1992-07-13
FR2560878B1 (fr) 1988-10-14
DE3507983A1 (de) 1985-09-12
DK100685A (da) 1985-09-07
HK82890A (en) 1990-10-19
FI84478C (fi) 1991-12-10
MX9203177A (es) 1992-07-01
SE462429B (sv) 1990-06-25
KR920005113B1 (ko) 1992-06-26
PT80058A (en) 1985-04-01
IT1183483B (it) 1987-10-22
GB2155925B (en) 1987-11-25
AU3944985A (en) 1985-09-12
DK166149B (da) 1993-03-15
KR920005114B1 (ko) 1992-06-26
PT80058B (pt) 1987-10-20
CH663022A5 (de) 1987-11-13
IT8519773A0 (it) 1985-03-05
IE850546L (en) 1985-09-06
SE8501067D0 (sv) 1985-03-05
GR850561B (hu) 1985-07-03
ES8607254A1 (es) 1986-05-16
AT390951B (de) 1990-07-25
DK100685D0 (da) 1985-03-05
ZA851486B (en) 1985-11-27
BE901880A (fr) 1985-09-05
AU576555B2 (en) 1988-09-01
FI84478B (fi) 1991-08-30
GB2155925A (en) 1985-10-02
IE58338B1 (en) 1993-09-08
CA1256871A (en) 1989-07-04
HU193949B (en) 1987-12-28

Similar Documents

Publication Publication Date Title
LU85796A1 (fr) Derives antipsychotiques de la 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine
EP0617028B1 (fr) Enantiomères de la 1-[(4-chlorophényl)phénylméthyl]-4-[(4-méthylphényl)sulfonyl] pipérazine
LU84011A1 (fr) 2-phenoxyalkyl-1,2,4-triazol-3-ones antidepressives
LU84561A1 (fr) 2-(4-((4,4,-dialcoyl-2,6-piperidinedione-1-yl)butyl)-1-piperazinyl)pyrimidines
FR2555585A1 (fr) Derives de la 1-heteroaryl-4 ((2,5-pyrrolidinedion-1-yl) alkyl )piperazine, leur procede de preparation et leur application pharmacologique
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
LU84550A1 (fr) Derives de piperazine portant un radical de benzisothiazole ou de benzisoxazole
LU85442A1 (fr) Agents antidepression a base de 1,2,4-triazol-3-one
FR2552759A1 (fr) Composes de la 1,2,4-triazolone et leur application pharmacologique
EP0429341A2 (fr) Dérivés hétérocycliques, leur préparation et les médicaments les contenant
FR2628425A1 (fr) Derives d'isoindolinone, leurs procedes de preparation et les medicaments les contenant
LU83616A1 (fr) N-((4-(pyridyl 3-substitue)piperazino)alkyl)azaspirodecanediones
EP1539738B1 (fr) Nouveaux derives d'aryl-4-halogeno-4- heteroarylmethylamino)-methyl -piperidin-1-yl-methanone,leur procede de preparation et leur utilisation a titre de medicaments
EP1828125B1 (fr) Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine
LU86405A1 (fr) Derive antipsychotique du benzisothiazole s-oxyde
FR2510571A1 (fr) Spirothiazolidinedione, son procede de production et preparation pharmaceutique la contenant
EP1187824B1 (fr) Derives de [(2-substitue-5-[3-thienyl)-benzyl]-[2-([2-isopropoxy-5-fluoro]-phenoxy)-ethyl]-amine, leur procede de preparation et leur utilisation a titre de medicaments
EP1023287B1 (fr) Derives de la 3-oxo-2(h)-1,2,4-triazine en tant que ligands des recepteurs 5ht1a
EP0120770B1 (fr) Dérivés de 2-aminoéthyl pyridine ou pyrazine, leur préparation et les compositions pharmaceutiques les contenant
CA2502528C (fr) Derives de 3-(cyclopenten-1-yl)-benzyl- ou 3-(cyclopenten-1-yl)-heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie
EP1119564B1 (fr) Derives d'aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone comme agonistes du recepteur 5-ht1
FR2543952A1 (fr) Composes hydrocarbones heterocycliques appartenant aux series indoliques et leur application pharmacologique
FR2731222A1 (fr) Nouveaux derives de piperazine aminoindoles cycliques, leur procede de preparation et leur utilisation a titre de medicaments
JPS6334152B2 (hu)
CN117999072A (zh) β肾上腺素能激动剂和其使用方法